Literature DB >> 3089242

Myocardial infarction in a young man with systemic lupus erythematosus, deep vein thrombosis, and antibodies to phospholipid.

R A Asherson, I R Mackay, E N Harris.   

Abstract

From the age of 17 a young man had recurrent venous thrombosis, with pulmonary embolism on two occasions. Laboratory investigations showed increased DNA binding, thrombocytopenia, positive antinuclear antibodies, and immunoglobulin A deficiency. A plasminogen activator deficiency was suspected because the euglobulin lysis time was considerably prolonged. Variant lupus was diagnosed. He had a severe myocardial infarct at the age of 20 and subsequent investigations showed the presence in serum of the lupus anticoagulant and antibodies to cardiolipin. The presence of these antiphospholipid antibodies explains the features of his illness and establishes that this case fits into a subset of systemic lupus erythematosus characterised by thrombotic events.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089242      PMCID: PMC1236835          DOI: 10.1136/hrt.56.2.190

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  12 in total

1.  Arterial occlusion causing large bowel infarction--a reflection of clotting diathesis in SLE.

Authors:  R A Asherson; S H Morgan; E N Harris; A E Gharavi; T Krausz; G R Hughes
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

2.  Coronary atherosclerosis and myocardial infarction associated with systemic lupus erythematosus.

Authors:  V G Tsakraklides; L C Blieden; J E Edwards
Journal:  Am Heart J       Date:  1974-05       Impact factor: 4.749

3.  Effect of treatment with combined phenformin and ethyloestrenol on the coagulation and fibrinolytic systems.

Authors:  S Isacson; I M Nilsson
Journal:  Scand J Haematol       Date:  1970

4.  Lupus anticoagulant, thrombosis, and fetal loss.

Authors:  D I Feinstein
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

5.  Arterial thrombosis, intrauterine death and "lupus" antiocoagulant: detection of immunoglobulin interfering with prostacyclin formation.

Authors:  L O Carreras; G Defreyn; S J Machin; J Vermylen; R Deman; B Spitz; A Van Assche
Journal:  Lancet       Date:  1981-01-31       Impact factor: 79.321

6.  Prekallikrein inhibition associated with the lupus anticoagulant: a mechanism of thrombosis.

Authors:  M J Sanfelippo; C J Drayna
Journal:  Am J Clin Pathol       Date:  1982-03       Impact factor: 2.493

7.  Subclavian artery thrombosis mimicking the aortic arch syndrome in systemic lupus erythematosus.

Authors:  F M Ferrante; G E Myerson; J A Goldman
Journal:  Arthritis Rheum       Date:  1982-12

8.  Recurrent ischemic attacks in two young adults with lupus anticoagulant.

Authors:  G Landi; M V Calloni; M Grazia Sabbadini; P Mannuccio Mannucci; L Candelise
Journal:  Stroke       Date:  1983 May-Jun       Impact factor: 7.914

9.  Thromboembolism in patients with the 'lupus'-type circulating anticoagulant.

Authors:  M Elias; A Eldor
Journal:  Arch Intern Med       Date:  1984-03

10.  Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant".

Authors:  R A Asherson; J G Lanham; R G Hull; M L Boey; A E Gharavi; G R Hughes
Journal:  Clin Exp Rheumatol       Date:  1984 Jan-Mar       Impact factor: 4.473

View more
  9 in total

1.  Antiphospholipid antibody syndrome in a case with redo coronary artery bypass grafting under cardiopulmonary bypass.

Authors:  M Nakayama; K Kumon; N Yahagi; M Haruna; Y Watanabe; H Hayashi
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

2.  Arterial occlusion causing large bowel infarction--a reflection of clotting diathesis in SLE.

Authors:  R A Asherson; S H Morgan; E N Harris; A E Gharavi; T Krausz; G R Hughes
Journal:  Clin Rheumatol       Date:  1986-01       Impact factor: 2.980

Review 3.  Vascular disease, thrombosis, and recurrent abortion.

Authors:  G R Hughes
Journal:  BMJ       Date:  1988-09-17

4.  Cerebrovascular accident and myocardial infarction associated with anticardiolipin antibodies in a young woman with systemic lupus erythematosus.

Authors:  Y Maaravi; E Raz; D Gilon; A Rubinow
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

5.  [Oxidatively modified lipoproteins and their antibodies in patients with antiphospholipid syndromeand systemic lupus erythematosus].

Authors:  B Roch; S Kopprasch; J Pietzsch; H-E Schröder
Journal:  Z Rheumatol       Date:  2004-08       Impact factor: 1.372

6.  Findings at necropsy in the heart of a patient with anticardiolipin syndrome.

Authors:  J J Murphy; I H Leach
Journal:  Br Heart J       Date:  1989-07

7.  Pulmonary haemorrhage, pulmonary infarction, and the lupus anticoagulant.

Authors:  H S Howe; M L Boey; K Y Fong; P H Feng
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

8.  Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities.

Authors:  A G Bird; R Lendrum; R A Asherson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

9.  Anticardiolipin antibodies in ischaemic heart disease: marker or myth?

Authors:  K V Phadke; R A Phillips; D T Clarke; M Jones; P Naish; P Carson
Journal:  Br Heart J       Date:  1993-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.